EN
IT
EMBRYOTEST: The next level in preimplantation genetic testing
Dear Customer,
GENOMICA is proud to introduce you EMBRYOTEST, the most advanced preimplantation genetic test that, using groundbreaking technologies, screens multiple genes to detect mutations causing severe inherited and de novo genetic disorders in preimplantation embryos.
EMBRYOTEST is a complement to Genomica's market-leading
test, which screens embryos for aneuploidies and segmental chromosome imbalances.
It has been designed to screen for:
• 26 common inherited recessive genetic disorders;
• 53 severe genetic disorders due to de novo mutations (a gene mutation that is not inherited) in 35 genes that cause skeletal dysplasia, congenital heart defects, multiple congenital malformation syndromes, neurodevelopmental disorders and sporadic cases of various rare dominant Mendelian disorders, such as Schinzel-Giedion syndrome and Bohring-Opitz syndrome.
It has been designed to:
• screen for 5000+ severe genetic disorders, inherited or due to de novo mutations;
• focus on the exonic regions of 4000+ disease-causing genes associated with known clinical phenotypes, thereby comprising the clinical exome.
• provide a more uniform and robust coverage and performance over genes of clinical interest.
It has been designed to:
• offer the most comprehensive level of screening currently available in preimplantation genetic testing field;
• screen for 5000+ severe genetic disorders, inherited or due to de novo mutations;
• focus on the exonic regions of 4000+ disease-causing genes associated with known clinical phenotypes, thereby comprising the clinical exome;
• provide a more uniform and robust coverage and performance over genes of clinical interest;
• screen for aneuploidies and structural chromosomal abnormalities.
DOWNLOAD EMBRYOTEST BROCHURE
Further information on EMBRYOTEST can be obtained through the website https://embryotest.it/ or by requesting the assistance of our team of geneticists.
If you are interested to receive more information about EMBRYOTEST, we invite you to write us at commerciale@genomicalab.it or fill our Online Contact Form.
Stay tuned, to learn about the most advanced and innovative diagnostic solutions in the genetics field.
GENOMICA srl
Marketing and Communication Department
GENOMICA is proud to introduce you EMBRYOTEST, the most advanced preimplantation genetic test that, using groundbreaking technologies, screens multiple genes to detect mutations causing severe inherited and de novo genetic disorders in preimplantation embryos.
EMBRYOTEST is a complement to Genomica's market-leading
test, which screens embryos for aneuploidies and segmental chromosome imbalances.A cutting-edge genetic test that offers a full panel of screening options
EMBRYOTEST involves 3 different levels of screening:It has been designed to screen for:
• 26 common inherited recessive genetic disorders;
• 53 severe genetic disorders due to de novo mutations (a gene mutation that is not inherited) in 35 genes that cause skeletal dysplasia, congenital heart defects, multiple congenital malformation syndromes, neurodevelopmental disorders and sporadic cases of various rare dominant Mendelian disorders, such as Schinzel-Giedion syndrome and Bohring-Opitz syndrome.
It has been designed to:
• screen for 5000+ severe genetic disorders, inherited or due to de novo mutations;
• focus on the exonic regions of 4000+ disease-causing genes associated with known clinical phenotypes, thereby comprising the clinical exome.
• provide a more uniform and robust coverage and performance over genes of clinical interest.
It has been designed to:
• offer the most comprehensive level of screening currently available in preimplantation genetic testing field;
• screen for 5000+ severe genetic disorders, inherited or due to de novo mutations;
• focus on the exonic regions of 4000+ disease-causing genes associated with known clinical phenotypes, thereby comprising the clinical exome;
• provide a more uniform and robust coverage and performance over genes of clinical interest;
• screen for aneuploidies and structural chromosomal abnormalities.
DOWNLOAD EMBRYOTEST BROCHURE
Further information on EMBRYOTEST can be obtained through the website https://embryotest.it/ or by requesting the assistance of our team of geneticists.
If you are interested to receive more information about EMBRYOTEST, we invite you to write us at commerciale@genomicalab.it or fill our Online Contact Form.
Stay tuned, to learn about the most advanced and innovative diagnostic solutions in the genetics field.
GENOMICA srl
Marketing and Communication Department